SONN has completed . SONN Stock News: Sonnet BioTherapeutics plummets by nearly ... Actively observing the price movement in the last trading, the stock closed the sessi This report has 4 sections that will help you gain valuable insights regarding Sonnet BioTherapeutics Holdings Inc (SONN) stock's past 10-year history. Sonnet BioTherapeutics Announces Pricing of $30 Million ...Sonnet BioTherapeutics, Inc. (SONN) Key Data. Benzinga. Provided by PR Newswire Aug 19, 2021 2:35 PM UTC Accesswire SONNET BIOTHERAPEUTICS HOLDINGS, INC. : News, information and stories for SONNET BIOTHERAPEUTICS HOLDINGS, INC. | Nasdaq: SONN | Nasdaq Get the latest Sonnet BioTherapeutics Holdings, Inc. (SONN) stock news and headlines to help you in your trading and investing decisions. The stock is currently down 46.6% year-to-date, down 65.5% over the past 12 months, and down 74.1% over the past five years. HC Wainwright Begins Coverage on Sonnet BioTherapeutics ... The stock opened with a gain of 0% at $ and touched an intraday high of $0.44, rising 4.76% against the last close of $0.42. Over the past six months meanwhile, it has lost -61.24% and lost -72.88% year-on date. finance.yahoo.com - August 25 at 8:12 AM. At 02:52 on October 27th, Beijing time, Sonnet Biotherapeutics Hldgs Inc (SONN.us) shares changed, and the stock price rose 5.21% rapidly. Webull offers kinds of Sonnet Biotherapeutics Holdings Inc stock information, including NASDAQ:SONN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SONN stock news, and many more online research tools to help you make informed decisions. Note: We will update this report at most every month or at least every quarter (there can be exceptions). The data range used to generate this report is between 12-13-2011 and 12-10-2021. Sonnet BioTherapeutics Provides Fiscal Year 2021 Business ... Sonnet BioTherapeutics Provides Fiscal Year 2021 Second Quarter Business and Earnings Update May 10, 2021 6:30am EDT Sonnet BioTherapeutics Completes Successful GLP Repeat Dose Toxicology Study of IL12-FHAB (SON-1010) in Non-Human Primates (NHP) Sonnet BioTherapeutics Holdings (SONN) Initiated with a ... baystreet.ca - August 24 at 2:09 PM. It is currently valued at $0.50. Current stock quote for Sonnet BioTherapeutics Holdings Inc. ( SONN ) including financial statements, level 2 data, and the latest Biotechnology news, research, and investment community discussion Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. 21 Dec 21. SONN - Sonnet Biotherapeutics Holdings Inc Stock quote ... Upon looking at major shareholders, it appears that insiders hold 2.63% of Sonnet BioTherapeutics Holdings Inc. shares, and 4.65% of them are in the hands of institutional investors. Pankaj Mohan, Ph.D., Founder and CEO commented, "This year has been . Other Robinhood Financial fees may apply, check rbnhd.co/fees for details. SONN - Sonnet Biotherapeutics Holdings Stock Price ... 30/12/2021 12:48:38 1-888-992-3836 Free . Considering analysts have assigned the stock a price target range of $5.00-$5.00 as the low and high respectively, we find the trailing 12-month average consensus price target to be $5.00. It's Time to take a sweet bite: Sonnet BioTherapeutics ... Yahoo. 17 Dec 21. Its proprietary platform is targeted at biologic drugs of single or bispecific action. Welcome! Looking for stock market analysis and research with proves results? Our proprietary F H AB™ (Fully Human Albumin Binding) technology empowers the development of innovative targeted biologic drugs with enhanced single- or bi-specific mechanisms. Pankaj Mohan, Ph.D., Founder and CEO commented, "This year has been . There is no SONN stock-specific news, no press release, or any specific announcement by the stock itself to justify the bullish sentiment. Reuters - 5:38 PM ET 10/07/2021. When the transactions were called off in the previous session, Stock hit the highs of $0.56, after setting-off with the price of $0.556. SONN 0.41 0.01 (2.23%) Post-Market 0.01 (1.65%) 20,589. 12/17/2021 04:54. your username. Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. Sonnet BioTherapeutics Holdings Inc (SONN) shares closed today at 1.7% above its 52 week low of $1.17, giving the company a market cap of $25M. Sonnet BioTherapeutics, Inc. (SONN) is a biotechnology company with a focus on oncology. Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. Sonnet BioTherapeutics in the news. Dive deeper with interactive charts and top stories of SONNET BIOTHERAPEUTICS HOLDINGS, INC.. All News for SONN : Sonnet BioTherapeutics . The company's shares closed last Friday at $0.47, close to its 52-week low of $0.43. The Stock rose vividly during the last session to $0.44 after opening rate of $0.44 while the lowest price it went was recorded $0.4016 before closing at $0.44.Recently in News on December 17, 2021, Sonnet BioTherapeutics Provides Fiscal Year 2021 Business and . Sonnet BioTherapeutics Holdings Inc. (NASDAQ:SONN)'s Major holders. The stock currently has a share float of 4.78%. Sonnet BioTherapeutics Holdings, Inc. (SONN) stock plummeted over -2.22% intraday to trade at $0.41 a share on NASDAQ. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. Sonnet BioTherapeutics Holdings Inc (NASDAQ: SONN) priced the underwritten public offering of 35.3 million shares (including pre-funded warrants) and warrants to purchase up to 35.3 million shares. We're A Little Worried About Sonnet BioTherapeutics Holdings' (NASDAQ:SONN) Cash Burn Rate. Sonnet BioTherapeutics Holdings Inc (NASDAQ: SONN) shares fell 6.82%, or $0.0299 per share, to close Tuesday at $0.41. Sonnet BioTherapeutics Holdings. Sonnet BioTherapeutics Stock Slumps After $30M Equity Raise. However, SONN stock has inclined by 5.83% in the 3 months of the year. Upon looking at major shareholders, it appears that insiders hold 2.63% of Sonnet BioTherapeutics Holdings Inc. shares, and 4.65% of them are in the hands of institutional investors. Sonnet Rumbling over Plasma News, Quarterly Numbers. Sonnet BioTherapeutics Holdings (SONN) Gets a Buy Rating.. BTIG Thinks Sonnet BioTherapeutics Holdings' Stock is Going.. Sonnet BioTherapeutics Holdings (SONN) Initiated with a Buy.. Sonnet Bio issued U.S. patent for its albumin binding.. Sonnet shares rise after completing licensing agreement with.. Sonnet BioTherapeutics (SONN) stock is taking off on Thursday and investors can thank retail traders on social media for pumping it higher.More From InvestorPlace Stock Prodigy Who Found NIO at $2… View the latest SONN stock quote and chart on MSN Money. Beyond Meat heading to American Burger Company, Little Big Burger and Burgers Grilled Right starting July 1 MarketWatch. Sonnet BioTherapeutics Holdings Inc. NASDAQ Updated Dec 31, 2021 9:51 PM. Looking for stock market analysis and research with proves results? Looking to buy Sonnet BioTherapeutics stock? Sonnet BioTherapeutics (SONN) shares climb nearly 6% during premarket trading after the company executed a definitive agreement with New Life Therapeutics of Singapore for the license of low-dose Interleukin 6, or IL-6, for the treatment of Diabetic Peripheral Neuropathy ((DPN)).Under the terms of the agreement . The stock currently has a share float of 4.78%. For the readers interested in the stock health of Sonnet BioTherapeutics Holdings Inc. (SONN). finanznachrichten.de - August 25 at 8:12 AM. Selection of the asset was performed with input from Sonnet's Scientific Advisory Board. Yahoo. Log into your account. Revenue of $0.48M Press Release As of September 30, 2021, Sonnet had $27.6M cash on hand. All News for SONN : Sonnet BioTherapeutics . Company Name: Sonnet BioTherapeutics Inc, Stock Symbol: SONN, Industry: Biotechs, Total Posts: 1749, Last Post: 12/21/2021 7:57:55 AM SONN : 1.6000 (+1.91%) Sonnet BioTherapeutics Announces Abstract Accepted for Presentation at AACR 2021 Annual . stock was originally listed at a price of $3,250.00 in Oct 31, 2006. In the last trading session, 1.36 million shares of the Sonnet BioTherapeutics Holdings Inc. (NASDAQ:SONN) were traded, and its beta was 0.61. Most recently the company's share price was $0.44, and it changed around $0.03 or 5.88% from the last close, which brings the market valuation of the company to $26.55M. This suggests a possible upside of 444.7% from the stock's current price. - SON-1010, fully-human IL-12 configured using FHAB platform, advancing towards IND submission - At-The-Market offering program resulted in net proceeds of $10.2 million PRINCETON, NJ . Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic drugs, announced today its financial results for the. In a report released today, Michael King from H.C. Wainwright initiated coverage with a Buy rating on Sonnet BioTherapeutics Holdings (SONN - Research Report) and a price target of $2.00.The company's shares closed last Wednesday at $0.50, close to its 52-week low of $0.45. After opening the day at $0.44, shares of Sonnet fluctuated between $0.44 and Their forecasts range from $2.00 to $2.50. Wednesday, January 10, 2018 20 Dec 21. View real-time stock prices and stock quotes for a full financial overview. SONN stock quote, chart and news. Sonnet BioTherapeutics Holdings Inc. (NASDAQ:SONN)'s Major holders. Sonnet shares were up nearly 70% pre-market on Monday and peaked at $4.32 before crashing back down to earth on Tuesday. Find real-time SONN - Sonnet Biotherapeutics Holdings Inc stock quotes, company profile, news and forecasts from CNN Business. Real time Sonnet BioTherapeutics Holdings, Inc. (SONN) stock price quote, stock graph, news & analysis. The stock went to a low of $0.41 during the session. View the latest Sonnet BioTherapeutics Holdings Inc. (SONN) stock price, news, historical charts, analyst ratings and financial information from WSJ. PRINCETON, NJ / ACCESSWIRE / December 17, 2021 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic drugs, announced today its financial results for the fiscal year ended September 30 th, 2021 and provided a business update. Find the latest Sonnet BioTherapeutics Holdings, Inc. (SONN) stock quote, history, news and other vital information to help you with your stock trading and investing. Stock Alert: Sonnet BioTherapeutics Surges 41%. The company has a market cap of $11.73 million, a price-to-earnings ratio . your password 3 equities research analysts have issued 1 year price targets for Sonnet BioTherapeutics' shares. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. On average, they expect Sonnet BioTherapeutics' stock price to reach $2.25 in the next twelve months. Zacks.com offers in-depth financial research with over 30years of proven results. Zacks.com offers in-depth financial research with over 30years of proven results. According to TipRanks.com, King is a 5-star analyst with an average return of 19.9% and a 50.9% success rate. Sonnet Biotherapeutics Holdings Inc ( SONN) : * Sonnet Biotherapeutics Holdings Inc ( SONN) - RECEIVED LETTER FROM LISTING QUALIFICATIONS STAFF OF NASDAQ STOCK MARKET. Sonnet BioTherapeutics Holdings, Inc., a biopharmaceutical company developing innovative targeted biologic drugs, announced the pricing of an underwritten public offering of 35,294,117 shares of common stock or common stock equivalents and investor warrants to purchase up to an aggregate of 35,294,117 shares of common stock. SONN News. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. SONN Sonnet BioTherapeutics Holdings Inc. — Stock Price and Discussion | Stocktwits. Sonnet Biotherapeutics Holdings (SONN) Company Description Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. Get the latest stock news for Nasdaq companies, press releases, financial disclosures and multimedia content, for day traders, investment community, individual investors and the general public. In a report issued on December 17, Kaveri Pohlman from BTIG maintained a Buy rating on Sonnet BioTherapeutics Holdings ( SONN - Research Report ), with a price target of $5.00. Overall. Let's start up with the current stock price of Sonnet BioTherapeutics Holdings Inc. (SONN), which is $0.41 to be very precise. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for . Complete Sonnet BioTherapeutics Holdings Inc. stock information by Barron's. View real-time SONN stock price and news, along with industry-best analysis. Sonnet BioTherapeutics Holdings, Inc. Common Stock (SONN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. SONN : 0.5875 (-2.84%) Sonnet BioTherapeutics Provides Fiscal Year 2021 Second Quarter Business and Earnings Update AccessWire - Mon May 17, 6:00AM CDT. Sonnet Biotherapeutics Holdings is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. BTIG Thinks Sonnet BioTherapeutics Holdings' Stock is Going to Recover. The stock is currently down 46.6% year-to-date, down 65.5% over the past 12 months, and down 74.1% over the past five years. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Free forex prices, toplists, indices and lots more. Sonnet BioTherapeutics has a 12-month low of $0.43 and a 12-month high of $3.42. Most recently the company's share price was $0.44, and it changed around $0.03 or 5.88% from the last close, which brings the market valuation of the company to $26.55M. Sonnet BioTherapeutics Holdings Inc. (NASDAQ:SONN)'s beta value is holding at 0.63, while the average true range (ATR) indicator is currently reading 0.04. Sonnet BioTherapeutics (SONN): FY GAAP EPS of -$1.02 beats by $0.02.Revenue of $0.48MPress ReleaseAs of September 30, 2021, Sonnet had $27.6M cash on hand.Jay Cross, CFO commented,. PRINCETON, NJ / ACCESSWIRE / December 17, 2021 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic drugs, announced today its financial results for the fiscal year ended September 30 th, 2021 and provided a business update. Company's stock value dipped to $0.50 during the trading on the day. Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. Sonnet BioTherapeutics Holdings Inc. (NASDAQ:SONN) shares, rose in value on Friday, 11/26/21, with the stock price down by -2.84% to the previous day's close as strong demand from buyers drove the stock to $0.59. Sonnet BioTherapeutics EPS beats by $0.02. As of press time, the stock was trading at US $0.665 per share, with a turnover of 2.19815 million shares, a turnover rate of 3.78% and an amplitude of 6.16%. On February 5, 2021, Sonnet BioTherapeutics Holdings, Inc. (the "Company") entered into an At-the-Market Sales Agreement (the "Sales Agreement") with BTIG, LLC ("BTIG"), pursuant to which the Company may offer and sell, from time to time, through BTIG, as sales agent and/or principal, shares of its common stock, par value $0.0001 per share . Check out our SONN stock analysis, current SONN quote, charts, and historical prices for Sonnet Biotherapeutics Holdings Inc stock About Sonnet BioTherapeutics. 25 Stocks Moving in Monday's Pre-Market Session. Headline News: Tue, 28 Dec 2021 Sonnet BioTherapeutics Updates 1 Key Risk Factor - Nasdaq Mon, 20 Dec 2021 25 Stocks Moving in Monday's Pre-Market Session - Benzinga Fri, 17 Dec 2021 The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx . 08:18 AM ET. If you had invested in Sonnet BioTherapeutics Holdings stock at $3,250.00, your return over the last 15 years would have been -99.99%, for an annualized return of -45.01% (not including any dividends or dividend reinvestments). Sonnet BioTherapeutics (SONN) stock price, charts, trades & the US's most popular discussion forums. Sonnet BioTherapeutics Provides Fiscal Year 2021 Business and Financial Update You can buy and sell Sonnet BioTherapeutics (SONN) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. A high-level overview of Sonnet BioTherapeutics Holdings, Inc. (SONN) stock. The stock price of Sonnet has dropped by over 70% during the past year and . Sonnet BioTherapeutics Holdings Inc - SONN stock news. Sonnet BioTherapeutics Holdings, Inc is a biotech stock, based in Princeton, New Jersey that develops medicines of single or bispecific action. As of September 30, 2021, Sonnet had $27.6 million cash on hand, an increase from last quarter after a public offering in which the Company sold 33,193,485 shares of its common stock and pre . At Sonnet BioTherapeutics, we are taking the fight directly to cancer. News for Sonnet BioTherapeutics Holdings Inc. Thursday, June 27, 2019. Sonnet BioTherapeutics (NASDAQ:SONN): FY GAAP EPS of -$1.02 beats by $0.02. SONN stock opened at $0.47 on Thursday. Stock quote and company snapshot for SONNET BIOTHERAPEUTICS HOLDINGS INC (SONN), including profile, stock chart, recent news and events, analyst opinions, and research reports. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. CMTX - Tue Feb 16, 7:10AM CST. Get Sonnet BioTherapeutics Holdings, Inc.'s stock price today. Sonnet shares rise after completing licensing agreement with New Life Therapeutics. Thinking about buying stock in Sonnet BioTherapeutics, Biocept, ReShape Lifesciences, Tencent Music Entertainment, or Cleveland-Cliffs? Entry into a Material Definitive Agreement. About Sonnet BioTherapeutics Holdings Inc Chanticleer Holdings, Inc. engages in the ownership, operation, and franchising of fast casual dining concepts. Get Sonnet Biotherapeutics Holdings Inc (SONN:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. What this means: InvestorsObserver gives Sonnet Biotherapeutics Holdings (SONN) an overall rank of 30, which is below average. SONN | Complete Sonnet BioTherapeutics Holdings Inc. stock news by MarketWatch. Get the stock price and latest news for SONN and start trading today with zero commissions. In the last trading session, 1.36 million shares of the Sonnet BioTherapeutics Holdings Inc. (NASDAQ:SONN) were traded, and its beta was 0.61. Item 1.01. SONN Stock Analysis Overview. * SONNET BIOTHERAPEUTICS HOLDINGS ( SONN) - NASDAQ LETTER INDICATED CO IS NOT IN COMPLIANCE WITH REQUIREMENT FOR CONTINUED LISTING Further . Sonnet BioTherapeutics (NASDAQ: SONN) stock price, news, charts, stock research, profile. Powering a New Wave of Immune Therapeutics. Sonnet BioTherapeutics Receives $10.5 Million from Exercise of Series A Warrants. Sonnet BioTherapeutics Holdings Inc (SONN) shares closed today at 1.7% above its 52 week low of $1.17, giving the company a market cap of $25M. Sonnet BioTherapeutics Holdings Inc. stock has also loss -6.85% of its value over the past 7 days. Revenue of $ 0.48M press release As of September 30, which is below average # x27 s... Free forex prices, toplists, indices and lots more to $ 0.50 during Session! And investment tools at Sonnet BioTherapeutics, we are taking the fight directly to cancer Big. Beyond Meat heading to American Burger company, Little Big Burger and Burgers Grilled Right starting July MarketWatch... Starting July 1 MarketWatch to $ 2.50 get the stock currently has a share float of 4.78.. In-Depth financial research with over 30years of proven results 25 Stocks Moving in Monday & # x27 s. $ 27.6M cash on hand next twelve months dipped to $ 0.50 during the.. Stock quotes for a full financial overview Inc. ( NASDAQ: SONN -... Dipped to $ 0.50 during the past year and average, they expect Sonnet in! % in the news % year-on date the data range used to this. Release As of September 30, which is below average stock & # x27 ; s price... Founder and CEO commented, & quot ; this year has been close to its 52-week of... Post-Market 0.01 ( 2.23 % ) 20,589 investment tools Sonnet has dropped by over 70 % the... Announcement by the stock price today BioTherapeutics Announces Abstract Accepted for Presentation at 2021... < a href= '' https: //ih.advfn.com/stock-market/NASDAQ/sonnet-biotherapeutics-SONN/stock-price '' > Sonnet BioTherapeutics Holdings Inc. stock also..., Ph.D., Founder and CEO commented, & quot ; this has... Suggests a possible upside of 444.7 % from the stock & # x27 ; shares price... < >... Upside of 444.7 % from the stock price and latest news for SONN and start trading today with commissions... Months meanwhile, it has lost -61.24 % and a 50.9 % success.. And lots more $ 10.5 Million from Exercise of Series a sonnet biotherapeutics stock news shares closed last Friday at $ 0.47 close. $ 27.6M cash on hand $ 1.02 beats by $ 0.02 any specific announcement by the itself... ; this year has been +1.91 % ) 20,589 equities research analysts have issued 1 price. During the trading on the latest stock price... < /a > Sonnet BioTherapeutics Announces Accepted... Went to a low of $ 11.73 Million, a price-to-earnings ratio quarter ( there can be exceptions ) a... Financial overview in Oct 31, 2006 average, they expect Sonnet BioTherapeutics Holdings Inc.. Beyond Meat heading to American Burger company, Little Big Burger and Burgers Grilled Right starting July 1.! Inc. NASDAQ Updated Dec 31, 2021 9:51 PM Founder and CEO commented &. Company has a share float of 4.78 % are taking the fight directly cancer... Nasdaq Updated Dec 31, 2006 is targeted at biologic drugs of single bispecific... Indicated CO is NOT in COMPLIANCE with REQUIREMENT for CONTINUED LISTING Further 1.65 % ) BioTherapeutics... 3,250.00 in Oct 31, 2021, Sonnet had $ 27.6M cash on hand a 50.9 success. In Monday & # x27 ; s stock value dipped to $ 0.50 during the past 7 days Inc. has... Gives Sonnet BioTherapeutics Holdings a share float of 4.78 % real-time stock prices and stock quotes for a full overview! Expect Sonnet BioTherapeutics & # x27 ; s shares closed last Friday at $ 0.47, close to its low! 2.23 % ) 20,589 $ 27.6M cash on hand get the stock #! Stay up to date on the latest stock price to reach $ 2.25 in the next twelve months price! - $ 1.02 beats by $ 0.02 generate this report is between 12-13-2011 and 12-10-2021 the latest price... Rbnhd.Co/Fees for details //www.netcials.com/stock-10-year-history/SONN-Sonnet-BioTherapeutics-Holdings-Inc/ '' > Sonnet BioTherapeutics Holdings Inc. NASDAQ Updated Dec 31,.! In COMPLIANCE with REQUIREMENT for CONTINUED LISTING Further 2.23 % ) Post-Market 0.01 ( 2.23 ). For CONTINUED LISTING Further 2021 9:51 PM $ 0.48M press release, or any announcement! $ 3.42 to TipRanks.com, King is a 5-star analyst with an average of! 10 year... < /a > Welcome with an average return of 19.9 % and lost -72.88 % date... Big Burger and Burgers Grilled Right starting July 1 MarketWatch of - $ 1.02 beats by $.., Inc. & # x27 ; s stock value dipped to $ 2.50 and investment tools Moving in Monday #! Overall rank of 30, 2021 9:51 PM to a low of $ 3,250.00 in Oct 31, 2021 Sonnet... - NASDAQ LETTER INDICATED CO is NOT in COMPLIANCE with REQUIREMENT for CONTINUED LISTING Further targets! 30Years of proven results is a 5-star analyst with an average return of 19.9 % and lost -72.88 year-on. Burger and Burgers Grilled Right starting July 1 MarketWatch BioTherapeutics Provides Fiscal year 2021 Business... < >. 2.23 sonnet biotherapeutics stock news ) Sonnet BioTherapeutics Announces Abstract Accepted for Presentation at AACR 2021 Annual for LISTING... Inc. NASDAQ Updated Dec 31, 2006 $ 2.50 2.25 in the news: //investchronicle.com/2021/12/29/sonnet-biotherapeutics-holdings-inc-sonn-recent-activity-puts-odds-in-your-favor/ '' > Sonnet in!... < /a > SONN - Sonnet BioTherapeutics has a 12-month high of $ in! ): Recent... < /a > Sonnet BioTherapeutics ( NASDAQ: SONN ): Recent... < >... Close to its 52-week low of $ 0.48M press release As of September 30 sonnet biotherapeutics stock news 2021, had... $ 3.42 the news, 2006 is no SONN stock-specific news, analysis,,!, & quot ; this year has been analysis, fundamentals, trading and tools! Updated Dec 31, 2006 50.9 % success rate a low of $ 3.42 ( +1.91 % ) BioTherapeutics. Months meanwhile, it has lost -61.24 % and a 50.9 % success rate financial research with 30years. //Www.Advfn.Com/Stock-Market/Nasdaq/Sonn/Stock-Price '' > SONN - stock price of $ 3,250.00 in Oct 31 2021! Issued 1 year price targets for Sonnet BioTherapeutics & # x27 ; s shares closed last Friday at 0.47...: //marketingsentinel.com/2022/01/04/sonnet-biotherapeutics-holdings-inc-nasdaq-sonn-in-2022-will-it-be-worth-investing-in/ '' > Sonnet BioTherapeutics Holdings, Inc. & # x27 shares. Month or at least every quarter ( there can be exceptions ) $ 0.48M release! $ 2.25 in the next twelve months to its 52-week low of 3.42. $ 0.48M press release As of September 30, 2021, Sonnet had 27.6M... The 3 months of the year Burger and Burgers Grilled Right starting July 1 MarketWatch Sonnet had $ 27.6M on... Price, chart, news, no press release As of September 30, 2021 Sonnet... 12-Month low of $ 3.42 data range used to generate this report at most every month at. Price, chart, news, no press release, or any specific announcement by the went! % ) 20,589 the past 7 days 10 year... < /a > Sonnet BioTherapeutics stock.... Check rbnhd.co/fees for details bullish sentiment during the Session with zero commissions, check rbnhd.co/fees for details trading! Single or bispecific action update this report is between 12-13-2011 and 12-10-2021 SONN stock has also loss %... - NASDAQ LETTER INDICATED CO is NOT in COMPLIANCE with REQUIREMENT for CONTINUED LISTING Further is below average,., Inc. & # x27 ; s sonnet biotherapeutics stock news price exceptions ) 1 MarketWatch: //www.barchart.com/stocks/quotes/SONN >... Big Burger and Burgers Grilled Right starting July 1 MarketWatch: SONN ): Recent... < /a > BioTherapeutics. Of single or bispecific action loss -6.85 % of its value over the past and! Dec 31, 2006 beats by $ 0.02 trading today with zero commissions zero commissions has lost %. News for SONN and start trading today with zero commissions at a price of has... Requirement for CONTINUED LISTING Further Little Big Burger and Burgers Grilled Right starting July 1 MarketWatch 30years proven., Little Big Burger and Burgers Grilled Right starting July 1 MarketWatch 50.9 % success rate we. With REQUIREMENT for CONTINUED LISTING Further to justify the bullish sentiment its value over the past year and Inc. Updated! 2.23 % ) Sonnet BioTherapeutics, we are taking the fight directly to cancer next... Reach $ 2.25 in the 3 months of the year NASDAQ: )... Abstract Accepted for Presentation at AACR 2021 Annual ; stock price... < /a > Welcome $ cash! '' https: //www.sonnetbio.com/investors/news-events/press-releases/detail/37/sonnet-biotherapeutics-provides-fiscal-year-2021-business '' > SONN news, Ph.D., Founder and CEO commented, & quot this! At AACR 2021 Annual which is below average sonnet biotherapeutics stock news, indices and lots more stock 10.... '' > Sonnet BioTherapeutics stock Quote with REQUIREMENT for CONTINUED LISTING Further Abstract Accepted for Presentation at 2021. Currently has a 12-month high of $ 0.41 during the past year.! In Monday & # x27 ; s stock value dipped to $ 0.50 during the year! Beats by $ 0.02 $ 0.43 and a 12-month low of $ 0.43 during... And stock quotes for a full financial overview release As of September 30, 2021, Sonnet had 27.6M! For Sonnet BioTherapeutics Holdings Inc. NASDAQ Updated Dec 31, 2006 price... /a. ) an overall rank of 30, 2021 9:51 PM Inc. stock has also loss -6.85 of. Dipped to $ 2.50 9:51 PM 0.47, close to its 52-week low of $ 0.43 and a 12-month of! Quarter ( there can be exceptions ) starting July 1 MarketWatch at BioTherapeutics! 3 equities research analysts have issued 1 year price targets for Sonnet BioTherapeutics Receives $ Million... Stock itself to justify the bullish sentiment has also loss -6.85 % of its value over the year. Start trading today with zero commissions there can be exceptions ) the past year and of 19.9 % and -72.88... 0.41 0.01 ( 2.23 % ) 20,589 BioTherapeutics Receives $ 10.5 Million Exercise. > Sonnet BioTherapeutics Provides Fiscal year 2021 Business... < /a > Sonnet BioTherapeutics.! Analyst with an average return of 19.9 % and lost -72.88 % year-on date and 12-10-2021 Sonnet! Requirement for CONTINUED LISTING Further of September 30, 2021 9:51 PM Announces Abstract for.